🇺🇸 rLP2086 vaccine in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 5
Most-reported reactions
- Acute Kidney Injury — 1 report (20%)
- Brain Injury — 1 report (20%)
- Cardiac Arrest — 1 report (20%)
- Overdose — 1 report (20%)
- Suicide Attempt — 1 report (20%)
Other Infectious Disease approved in United States
Frequently asked questions
Is rLP2086 vaccine approved in United States?
rLP2086 vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for rLP2086 vaccine in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.